메뉴 건너뛰기




Volumn 363, Issue 4, 2010, Pages 301-304

The path to personalized medicine

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; IMATINIB; RITUXIMAB; TRASTUZUMAB;

EID: 77954827460     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1006304     Document Type: Short Survey
Times cited : (1568)

References (5)
  • 1
    • 48249123433 scopus 로고    scopus 로고
    • Pharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: Prevalence of related drug use
    • Frueh FW, Amur S, Mummaneni P, et al. Pharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: prevalence of related drug use. Pharmacotherapy 2008; 28:992-8.
    • (2008) Pharmacotherapy , vol.28 , pp. 992-998
    • Frueh, F.W.1    Amur, S.2    Mummaneni, P.3
  • 3
    • 0003445355 scopus 로고    scopus 로고
    • Secretary's Advisory Committee on Genetic Testing. Bethesda, MD: Accessed June 11, 2010, at
    • Secretary's Advisory Committee on Genetic Testing. Enhancing the oversight of genetic tests: recommendations of the SACGT. Bethesda, MD: National Institutes of Health, 2000. (Accessed June 11, 2010, at http://oba.od.nih.gov/ oba/sacgt/reports/oversight-report.pdf.)
    • (2000) Enhancing the Oversight of Genetic Tests: Recommendations of the SACGT
  • 5
    • 77954821378 scopus 로고    scopus 로고
    • Bethesda, MD: National Center for Biotechnology, Accessed June 11, 2010, at
    • Genetic Testing Registry. Bethesda, MD: National Center for Biotechnology, National Library of Medicine; 2010. (Accessed June 11, 2010, at http://www.ncbi.nlm.nih.gov/gtr.)
    • (2010) Genetic Testing Registry


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.